These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 37842592)

  • 21. Construction and Validation of an Immune-Based Prognostic Model for Pancreatic Adenocarcinoma Based on Public Databases.
    Mao M; Ling H; Lin Y; Chen Y; Xu B; Zheng R
    Front Genet; 2021; 12():702102. PubMed ID: 34335699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathological features, prognostic significance, and associated tumor cell functions of family with sequence similarity 111 member B in pancreatic adenocarcinoma.
    Gong Q; Dong Q; Zhong B; Zhang T; Cao D; Zhang Y; Ma D; Cai X; Li Z
    J Clin Lab Anal; 2022 Dec; 36(12):e24784. PubMed ID: 36408702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CTSK and PLAU as Prognostic Biomarker and Related to Immune Infiltration in Pancreatic Cancer: Evidence from Bioinformatics Analysis and qPCR.
    Ding Y; Li Z; Wang H; Wang Q; Jiang H; Yu Z; Xu M
    Int J Genomics; 2023; 2023():3914687. PubMed ID: 38077303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor mutation burden-related long non-coding RNAs is predictor for prognosis and immune response in pancreatic cancer.
    Wang C; Wang Z; Zhao Y; Jia R
    BMC Gastroenterol; 2022 Nov; 22(1):495. PubMed ID: 36451085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and validation of a hypoxia-stemness-based prognostic signature in pancreatic adenocarcinoma.
    Tian X; Zheng J; Mou W; Lu G; Chen S; Du J; Zheng Y; Chen S; Shen B; Li J; Wang N
    Front Pharmacol; 2022; 13():939542. PubMed ID: 35935823
    [No Abstract]   [Full Text] [Related]  

  • 26. Identify potential prognostic indicators and tumor-infiltrating immune cells in pancreatic adenocarcinoma.
    Shi T; Gao G
    Biosci Rep; 2022 Feb; 42(2):. PubMed ID: 35083488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modeling of new markers for the diagnosis and prognosis of pancreatic cancer based on the transition from inflammation to cancer.
    Zhou Y; Huang B; Zhang Q; Yu Y; Xiao J
    Transl Cancer Res; 2024 Mar; 13(3):1425-1442. PubMed ID: 38617519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioinformatics analysis identified MMP14 and COL12A1 as immune-related biomarkers associated with pancreatic adenocarcinoma prognosis.
    Li Y; Su Z; Wei B; Qin M; Liang Z
    Math Biosci Eng; 2021 Jun; 18(5):5921-5942. PubMed ID: 34517516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and validation of a novel glycolysis-related risk signature for predicting survival in pancreatic adenocarcinoma.
    Li A; Hou S; Chen J; Jiang Y
    Clin Chim Acta; 2021 Jul; 518():156-161. PubMed ID: 33775699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CXCL10 is a Tumor Microenvironment and Immune Infiltration Related Prognostic Biomarker in Pancreatic Adenocarcinoma.
    Huang H; Zhou W; Chen R; Xiang B; Zhou S; Lan L
    Front Mol Biosci; 2021; 8():611508. PubMed ID: 33681290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and validation of a prognostic prediction model for iron metabolism-related genes in patients with pancreatic adenocarcinoma.
    Wei W; Cao B; Xu D; Liu Y; Zhang X; Wang Y
    Front Genet; 2022; 13():1058062. PubMed ID: 36685915
    [No Abstract]   [Full Text] [Related]  

  • 32. Identification of the Real Hub Gene and Construction of a Novel Prognostic Signature for Pancreatic Adenocarcinoma Based on the Weighted Gene Co-expression Network Analysis and Least Absolute Shrinkage and Selection Operator Algorithms.
    Yuan Q; Ren J; Wang Z; Ji L; Deng D; Shang D
    Front Genet; 2021; 12():692953. PubMed ID: 34490033
    [No Abstract]   [Full Text] [Related]  

  • 33. Development and validation of a metastasis-related Gene Signature for predicting the Overall Survival in patients with Pancreatic Ductal Adenocarcinoma.
    Wu M; Li X; Liu R; Yuan H; Liu W; Liu Z
    J Cancer; 2020; 11(21):6299-6318. PubMed ID: 33033514
    [No Abstract]   [Full Text] [Related]  

  • 34. Crosstalk of ferroptosis regulators and tumor immunity in pancreatic adenocarcinoma: novel perspective to mRNA vaccines and personalized immunotherapy.
    Shi Y; Wang Y; Dong H; Niu K; Zhang W; Feng K; Yang R; Zhang Y
    Apoptosis; 2023 Oct; 28(9-10):1423-1435. PubMed ID: 37369808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of m6A-related genes in the prognosis and immune microenvironment of pancreatic adenocarcinoma.
    Tang R; Zhang Y; Liang C; Xu J; Meng Q; Hua J; Liu J; Zhang B; Yu X; Shi S
    PeerJ; 2020; 8():e9602. PubMed ID: 33062408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Construction and validation of a m6A RNA methylation and ferroptosis-related prognostic model for pancreatic cancer by integrated bioinformatics analysis.
    Wu T; Qian TY; Lin RJ; Jin DD; Xu XB; Huang MX; Ji J; Jiang F; Pan LL; Luo L; Ji YF; Chen QL; Xiao MB
    J Gastrointest Oncol; 2022 Oct; 13(5):2553-2564. PubMed ID: 36388690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive Pan-Cancer Analysis of KIF18A as a Marker for Prognosis and Immunity.
    Liu T; Yang K; Chen J; Qi L; Zhou X; Wang P
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830695
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Zheng Q; Xie Y; Xu L; Chen D; Wu J; Liu S; Wu L; Fang P; Xie F
    J Gastrointest Oncol; 2024 Aug; 15(4):1746-1759. PubMed ID: 39279982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SQLE, A Key Enzyme in Cholesterol Metabolism, Correlates With Tumor Immune Infiltration and Immunotherapy Outcome of Pancreatic Adenocarcinoma.
    You W; Ke J; Chen Y; Cai Z; Huang ZP; Hu P; Wu X
    Front Immunol; 2022; 13():864244. PubMed ID: 35720314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Prognostic Value and the Oncogenic and Immunological Roles of Vacuolar Protein Sorting Associated Protein 26 A in Pancreatic Adenocarcinoma.
    Hou J; Wu H; Xu B; Shang J; Xu X; Li G; Zhang H; Zhang W; Deng Y; Hong X; Hu T; Zhang M; Zhan Y
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.